Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,027 public trials 2,025 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Active, Not Recruiting

Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN

NCT03386513

Conditions
Blastic Plasmacytoid Dendritic Cell Neoplasm, Bone Marrow Diseases, Disease Attributes, +25 more
Locations
  • Banner Health MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope Medical Center Duarte, California, United States
  • UCLA Los Angeles, California, United States
  • Stanford Stanford, California, United States
View all 28 locations
View Trial Details
Active, Not Recruiting

A Trial Assessing the Effect of Pembrolizumab Combined with Radiotherapy in Patients with Relapsed, Refractory, Specified Stages of Cutaneous T-cell Lymphoma (CTCL) Mycosis Fungoides (MF)/Sezary Syndrome (SS)

NCT03385226

Conditions
Cutaneous T Cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +16 more
Locations
  • University Hospital Birmingham Birmingham, United Kingdom
  • Velindre Cancer Centre Cardiff, United Kingdom
  • University Hospital Coventry Coventry, United Kingdom
  • Beatson West of Scotland Cancer Centre Glasgow, United Kingdom
View Trial Details
Active, Not Recruiting

RadiothErapy priMIng for CAR-T

NCT04726787

Conditions
Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • St James's University Hospital Leeds, United Kingdom
  • Kings College Hospital London, United Kingdom
  • Freeman Hospital Newcastle, United Kingdom
View Trial Details
Active, Not Recruiting

Carfilzomib/Cyclophosphamide/Dexamethasone with Maintenance Carfilzomib in Multiple Myeloma

NCT02315716

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Queen's Hospital Romford, Essex, United Kingdom
  • Royal United Hospital Bath, United Kingdom
  • Birmingham Heartlands Hospital Birmingham, United Kingdom
  • NHS Lanarkshire Bothwell, United Kingdom
View all 20 locations
View Trial Details
Active, Not Recruiting

Pomalidomide in Relapsed and Refractory Multiple Myeloma (RRMM)

NCT02406222

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Belfast Health & Social Care Trust Belfast, United Kingdom
  • University of Birmingham NHS Foundation Trust Birmingham, United Kingdom
  • Birmingham Heartlands Hospital Birmingham, United Kingdom
  • Royal Sussex County Hospital Brighton, United Kingdom
View all 21 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Safety and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With Polatuzumab Vedotin in B-Cell Non-Hodgkin Lymphoma

NCT03671018

Conditions
B-Cell Non-Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • University of Alabama at Birmingham School of Medicine Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • University of Colorado Hospital - Anschutz Cancer Pavilion Aurora, Colorado, United States
  • University of Miami Miller School of Medicine Miami, Florida, United States
View all 29 locations
View Trial Details

Related conditions